FDA authorizes protein-based Novavax Covid vaccine for adults | Omicron variant | The Guardian
Approval of shot widens options against the virus as CDC will meet next week to decide whether to sign off on vaccine
Novavax - Notfallzulassung in den USA ab 18 Jahren
- Details
